Figure 2.
PFS and OS rates of the most and least intensive treatment arms in the HD10 trial at 10-year follow-up. PFS (A) and OS (B) in patients treated in the most (blue) and least (yellow) intensive arms in the HD10 trial. Reprinted from Sasse et al5 with permission.
